ARIALYS
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jan 2026)
What this means for you
This application is over — abandoned 26 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97153379
- Mark type
- Stylized text
- Filed
- 02 Dec 2021
- Published for opposition
- 25 Oct 2022
- Abandoned
- 26 Jan 2026
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: Allergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; tumor suppressing agents; pain relief medication; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating hypertension; anaesthetics; alcohol for pharmaceutical purposes; diagnostic reagents for medical use; capsules sold empty for pharmaceuticals; dietetic preparations adapted for medical purposes; adhesive plasters for medical purposes; medical dressings; teeth filling material; lacteal flour for babies; nutritional supplements; baby food; dietary supplements for animals; semen for artificial insemination
- Class 042 — Scientific and technological services: Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; chemical analysis; bacteriological research; biological research; conducting clinical trials for others; scientific research; scientific laboratory services
Owner
- Arialys Therapeutics, Inc., La Jolla, CA, US
- Arialys Therapeutics, Inc., La Jolla, CA, US
Prosecution history
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2025 — SOU EXTENSION 5 GRANTED
- 17 Jun 2025 — SOU EXTENSION 5 FILED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2024 — SOU EXTENSION 4 GRANTED
- 05 Dec 2024 — SOU EXTENSION 4 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED